SCYNEXIS INC Intellectual Property Contracts & Agreements
11 Contracts & Agreements
- License Agreements (11 contracts)
- Binding Memorandum of Understanding for Amendment to Exclusive License Agreement and Transitional Manufacturing and Supply Agreement, dated as of December 26, 2023, by and between... (Filed With SEC on March 28, 2024)
- Third Amendment to License Agreement between SCYNEXIS, Inc. and Merck Sharp & Dohme Corp. dated December 21, 2016 (Filed With SEC on May 8, 2018)
- Additional Agreement No. 3 to the Development, License and Supply Agreement, dated August 1st, 2013, between SCYNEXIS, Inc. and R-Pharm, CJSC (Filed With SEC on November 7, 2017)
- Additional Agreement No. 2 to the Development, License and Supply Agreement, dated August 1st, 2013, between SCYNEXIS, Inc. and R-Pharm, CJSC (Filed With SEC on November 7, 2017)
- Amendment to the Development, License and Supply Agreement, dated August 1st, 2013, between SCYNEXIS, Inc. and R-Pharm, CJSC (Filed With SEC on November 7, 2017)
- EXCLUSIVE LICENSE AGREEMENT BETWEEN WATERSTONE PHARMACEUTICAL (HK) LIMITED AND SCYNEXIS, INC. DATED AS OF October 29, 2014 (Filed With SEC on March 30, 2015)
- AMENDED and RESTATED LICENSE, DEVELOPMENT & COMMERCIALIZATION AGREEMENT Between SCYNEXIS, Inc. And ELANCOANIMAL HEALTH, a division of ELI LILLY AND COMPANY (Filed With SEC on March 19, 2014)
- LICENSE AGREEMENT (Filed With SEC on March 19, 2014)
- DEVELOPMENT, LICENSE AND SUPPLY AGREEMENT BETWEEN R-PHARM, CJSC AND SCYNEXIS, INC. DATED AS OF August 1st, 2013 (Filed With SEC on March 19, 2014)
- AMENDMENT 1 TO THEEXCLUSIVE WORLD-WIDE LICENSE AGREEMENT ENTERED INTO BY AND BETWEEN SCYNEXIS Inc and AVENTIS PHARMA S.A. ON MAY THE 10th, 2005 (Filed With SEC on February 27, 2014)
- LICENSE AGREEMENT (Filed With SEC on February 27, 2014)
